Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19

Show other versions (1)

Coronavirus disease 2019 (COVID-19) is a respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the complexity of multimorbidity in Indonesia, it is crucial to find another line of antiviral for COVID-19. This article aims to review two antivirals, mol...

Full description

Bibliographic Details
Published in:Acta Medica Indonesiana
Main Authors: Samuel Theodorus Sutanto, Robert Sinto, Adeline Pasaribu, Sharifah Shakinah
Format: Article
Language:English
Published: Interna Publishing 2022-12-01
Subjects:
antiviral
covid-19
molnupiravir
nirmatrelvir/ritonavir
sars-cov-2
Online Access:https://actamedindones.org/index.php/ijim/article/view/2115

Internet

https://actamedindones.org/index.php/ijim/article/view/2115

Similar Items